Compare ARK Genomic Revolution ETF (ARKG) vs W W Grainger Inc (GWW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs W W Grainger Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while W W Grainger Inc trades at $1,375.73 (market cap $64.95B). The key difference: W W Grainger Inc pays a 0.67% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | GWW | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $1.38K |
52-Week Low | $23.09 | $918.18 |
Market Cap | — | $64.95B |
Enterprise Value | — | $67.04B |
Dividend Yield | — | 0.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GWW trades at $1,375.76, up 0.8% recently, with a bullish technical signal from moving averages and strong support at $1,356. The company reported Q1 2026 EPS of $11.65, beating estimates, and raised full-year guidance, reflecting robust MRO demand. Revenue growth to $18.4B in 2026 and a high ROE of 48.1% underscore operational strength, though valuation multiples like P/E of 36.99 appear elevated relative to historical norms.
Outlook is positive driven by earnings momentum and dividend consistency, but risks include high valuation sensitivity and industrial sector cyclicality. Analyst consensus is mixed with a $1,260 price target, suggesting cautious optimism amid growth execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About W W Grainger Inc
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →
